SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL
Product details
Registration number: SIN14851P
Classification: Prescription Only
Active ingredients: Tedizolid 165mg eqv Tedizolid phosphate
Strength: 200mg
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: MSD PHARMA (SINGAPORE) PTE. LTD.
ATC code: J01XX11
HSA approval date: 16 September 2015
Manufacturer(s): Patheon Italia S.p.A.
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14851P
Classification: Prescription Only
What active ingredients and strength are recorded for SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tedizolid 165mg eqv Tedizolid phosphate
Strength: 200mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: MSD PHARMA (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Patheon Italia S.p.A.
Manufacturing country/countries: ITALY
Where can I look up SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14851P or the exact product name SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL. The general register link does not preselect this product.
What are the source dates for this SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SIVEXTRO LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION 200MG PER VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14851P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)